Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P L Meroni

Showing results (221-230 of 265) with videos related to

Pageof 27
Sort By:
Clinical Immunology and Immunopathology|June 1, 1992
Antibodies to endothelial cells in primary vasculitides mediate in vitro endothelial cytotoxicity in the presence of normal peripheral blood mononuclear cellsN del Papa, P L Meroni, W Barcellini, et al.
Journal of Acquired Immune Deficiency Syndromes|October 1, 1993
Autoantibodies against beta 2-microglobulin-free HLA antigens in AIDS patientsM O Borghi, C De Santis, W Barcellini, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1996
Pathogenic role of anti-endothelial cell antibodies in vasculitis. An idiotypic experimental modelM Damianovich, B Gilburd, J George, et al.
Drugs Under Experimental and Clinical Research|January 1, 1993
[Effect of pidotimod on the function of the human immune system: in vitro and ex vivo study]M O Borghi, F Minonzio, C Fain, et al.
Scandinavian Journal of Immunology|September 1, 1992
The effects of deoxyspergualin on the development of diabetes in diabetes-prone BB ratsF Nicoletti, P L Meroni, R Di Marco, et al.
European Journal of Endocrinology|May 1, 1995
Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2aD Preziati, L La Rosa, G Covini, et al.
Autoimmunity|January 1, 1991
Enhanced percentage of Leu M3+DR+ and Leu M3+CD25+ cells in newly diagnosed IDDM patientsF Nicoletti, U Consoli, D Calogero, et al.
Reumatismo|November 6, 2010
[Subpopulations of anti-β₂glycoprotein I antibodies with different pathogenic potential: fine specificity against the domains of β₂glycoprotein I]L Andreoli, C Nalli, M Motta, et al.
Epilepsia|March 7, 2002
Prevalence of anti-cardiolipin, anti-beta2 glycoprotein I, and anti-prothrombin antibodies in young patients with epilepsyR Cimaz, A Romeo, A Scarano, et al.
Arthritis and Rheumatism|March 1, 1997
Endothelial cells as target for antiphospholipid antibodies. Human polyclonal and monoclonal anti-beta 2-glycoprotein I antibodies react in vitro with endothelial cells through adherent beta 2-glycoprotein I and induce endothelial activationN Del Papa, L Guidali, A Sala, et al.
Pageof 27

Showing results (221-230 of 265) with videos related to

Sort By:
Pageof 27
Clinical Immunology and Immunopathology|June 1, 1992
Antibodies to endothelial cells in primary vasculitides mediate in vitro endothelial cytotoxicity in the presence of normal peripheral blood mononuclear cellsN del Papa, P L Meroni, W Barcellini, et al.
Journal of Acquired Immune Deficiency Syndromes|October 1, 1993
Autoantibodies against beta 2-microglobulin-free HLA antigens in AIDS patientsM O Borghi, C De Santis, W Barcellini, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1996
Pathogenic role of anti-endothelial cell antibodies in vasculitis. An idiotypic experimental modelM Damianovich, B Gilburd, J George, et al.
Drugs Under Experimental and Clinical Research|January 1, 1993
[Effect of pidotimod on the function of the human immune system: in vitro and ex vivo study]M O Borghi, F Minonzio, C Fain, et al.
Scandinavian Journal of Immunology|September 1, 1992
The effects of deoxyspergualin on the development of diabetes in diabetes-prone BB ratsF Nicoletti, P L Meroni, R Di Marco, et al.
European Journal of Endocrinology|May 1, 1995
Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2aD Preziati, L La Rosa, G Covini, et al.
Autoimmunity|January 1, 1991
Enhanced percentage of Leu M3+DR+ and Leu M3+CD25+ cells in newly diagnosed IDDM patientsF Nicoletti, U Consoli, D Calogero, et al.
Reumatismo|November 6, 2010
[Subpopulations of anti-β₂glycoprotein I antibodies with different pathogenic potential: fine specificity against the domains of β₂glycoprotein I]L Andreoli, C Nalli, M Motta, et al.
Epilepsia|March 7, 2002
Prevalence of anti-cardiolipin, anti-beta2 glycoprotein I, and anti-prothrombin antibodies in young patients with epilepsyR Cimaz, A Romeo, A Scarano, et al.
Arthritis and Rheumatism|March 1, 1997
Endothelial cells as target for antiphospholipid antibodies. Human polyclonal and monoclonal anti-beta 2-glycoprotein I antibodies react in vitro with endothelial cells through adherent beta 2-glycoprotein I and induce endothelial activationN Del Papa, L Guidali, A Sala, et al.
Pageof 27